DSM and Brains Bioceutical form exclusive global partnership to unlock the therapeutic potential of cannabinoids in early-stage drug development
22 Jun 2021
Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, announces it has entered into an exclusive commercial partnership with global leader and pioneer in cannabinoid active pharmaceutical ingredients (APIs), Brains Bioceutical.